Consultancy

RenaSci’s consultancy team has a successful track record in pharmaceutical Research and Development having taken 15 drug candidates into clinical development and 3 drugs to the market.

Our regulatory experience includes dossier preparation and face-to-face interaction with the FDA, EMEA and many other regulatory agencies, including Japan.

Our intellectual property (IP) experience includes inventorship on 40 patents and the creation and writing of 30 more patents for various clients.

We have provided expert witness support for clients on intellectual property and drug pricing legal cases.

We have conducted drug abuse liability evaluations, including study design, management, dossier preparation and face-to-face meetings with the FDA, DEA, EMEA, and other global agencies.

Consultancy is offered in a wide range of areas, including drug discovery, preclinical and clinical development, regulatory approval, intellectual property protection and market positioning.

For further information, to order a brochure, or to discuss your requirements, please contact us:

Email: inform@renasci.co.uk  
Telephone: +44 (0) 115 912 4260
FAX: +44 (0) 115 912 4263